Moderna vaccine is second to exceed expectations; mutated virus may be more vulnerable to new vaccines
Moderna Inc's experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on...

Full story is loading. Click here if it doesn't...

Advertisement